<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5AC728E-4C27-48BA-AC28-E71F6BDF1960"><gtr:id>A5AC728E-4C27-48BA-AC28-E71F6BDF1960</gtr:id><gtr:name>Government of South Africa</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D15CCA84-D33E-4A13-87B9-8BC2F6EA18B3"><gtr:id>D15CCA84-D33E-4A13-87B9-8BC2F6EA18B3</gtr:id><gtr:name>University of Malaya</gtr:name><gtr:address><gtr:line1>50603 Kuala Lumpur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Malaysia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E78700A-3CCE-4011-870F-7B91E0741F8B"><gtr:id>7E78700A-3CCE-4011-870F-7B91E0741F8B</gtr:id><gtr:name>LRS Institute of Tuberculosis and Respiratory Diseases</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Infection and Population Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5AC728E-4C27-48BA-AC28-E71F6BDF1960"><gtr:id>A5AC728E-4C27-48BA-AC28-E71F6BDF1960</gtr:id><gtr:name>Government of South Africa</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D15CCA84-D33E-4A13-87B9-8BC2F6EA18B3"><gtr:id>D15CCA84-D33E-4A13-87B9-8BC2F6EA18B3</gtr:id><gtr:name>University of Malaya</gtr:name><gtr:address><gtr:line1>50603 Kuala Lumpur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Malaysia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E78700A-3CCE-4011-870F-7B91E0741F8B"><gtr:id>7E78700A-3CCE-4011-870F-7B91E0741F8B</gtr:id><gtr:name>LRS Institute of Tuberculosis and Respiratory Diseases</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DE956CB8-1DF4-49EB-BC34-78BD6095649A"><gtr:id>DE956CB8-1DF4-49EB-BC34-78BD6095649A</gtr:id><gtr:name>University of KwaZulu-Natal</gtr:name><gtr:address><gtr:line1>Govan Mbeki Centre</gtr:line1><gtr:line2>Westville Campus</gtr:line2><gtr:line3>Private Bag X54001</gtr:line3><gtr:postCode>4000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CEEF53C6-A297-4F16-AE18-1FCBA687C889"><gtr:id>CEEF53C6-A297-4F16-AE18-1FCBA687C889</gtr:id><gtr:firstName>Lewis</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Haddow</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700530"><gtr:id>9D302B02-0D6E-434C-B3DA-470C5F6AF94E</gtr:id><gtr:title>Epidemiology of HIV-Related Immune Reconstitution Inflammatory Syndrome in sub-Saharan Africa</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700530</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Between 10% and 40% of patients who start highly active antiretroviral therapy (HAART) experience a syndrome of an excessive inflammatory response and a paradoxical deterioration in clinical status. This phenomenon is thought to be due to a HAART-associated recovery of pathogen-specific immune responses to pre-existing or latent infections, and has been termed immune reconstitution inflammatory syndrome (IRIS). The clinical spectrum is diverse and cases of IRIS associated with more than 20 different pathogens have been described. IRIS represents a major diagnostic challenge in patients who have recently started HAART, and severe IRIS may result in organ failure, hospitalization or death.
There have been few systematic studies on the frequency, risk factors and clinical course of IRIS, and none to date undertaken in sub-Saharan Africa. It is anticipated that the problem of IRIS will be even more significant with HAART roll-out programmes in less developed countries where the underlying prevalence of infections such as Mycobacterium tuberculosis, Cryptococcus neoformans and hepatitis B is high, and patients initiating HAART are more likely to have advanced immunodeficiency. A greater understanding of the epidemiology, diagnostic criteria, clinical outcome and pathogenesis of IRIS in a sub-Saharan African setting is urgently needed to develop more effective strategies to diagnose, manage and prevent IRIS. The IRIS Collaborative Research Group represents a collaboration between the department of HIV/GUM at King?s College, London, and the Nelson R Mandela School of Medicine, aiming to complete the first comprehensive prospective study of IRIS in Africa. 
The principal aim of this study is to characterize the epidemiology of IRIS in patients starting HAART in KwaZulu-Natal. Specific objectives: (i) to determine the incidence, clinical spectrum and clinical features of IRIS, and the baseline seroprevalence of the main HIV-related infectious pathogens in patients initiang HAART; (ii) to refine the diagnostic criteria for IRIS, and identify overall and pathogen-risk factors for IRIS; (iii) to determine the clinical outcome of IRIS, particularly the contribution to early mortality after HAART initiation. 
1000 HIV-1 infected adult antiretroviral-naove patients initiating HAART at three ARV roll-out clinics in the Durban area will be enrolled over six months into a prospective observational cohort study. Patients will be monitored closely for six months for the development of IRIS events. Clinical data and sample collection will coincide with the routine schedule of baseline and monthly follow-up visits. Samples will be stored for serological batch testing to identify pathogen-related risk factors for IRIS. Univariate and multivariate logistic regression analyses will be used to identify independent demographic, clinical and laboratory risk factors for IRIS.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-15</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>345142</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>LRS Institute of Tuberculosis and Respiratory Diseases</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Vitamin D and TB-associated IRIS</gtr:description><gtr:id>EBEBE7A6-95AA-4221-A688-C69D616C2452</gtr:id><gtr:impact>The collaboration involves immunology, genetics and epidemiology expertise.
Abstract presented at Australasian HIV/AIDS Conference 2011. (Paper submitted for publication.)</gtr:impact><gtr:outcomeId>DgFc7wkzfUU-2</gtr:outcomeId><gtr:partnerContribution>Developing an understanding of immunogenetics and nutritional aspects of IRIS in TB/HIV co-infected patients.See above.See above.</gtr:partnerContribution><gtr:piContribution>One of 3 sites contributing clinical and laboratory data. All sites participated in analysis of results and dissemination of findings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malaya</gtr:collaboratingOrganisation><gtr:country>Malaysia</gtr:country><gtr:department>Centre of Excellence for Research in AIDS (CERiA)</gtr:department><gtr:description>Vitamin D and TB-associated IRIS</gtr:description><gtr:id>6C278273-0908-4A87-B40E-E700AF12EA9B</gtr:id><gtr:impact>The collaboration involves immunology, genetics and epidemiology expertise.
Abstract presented at Australasian HIV/AIDS Conference 2011. (Paper submitted for publication.)</gtr:impact><gtr:outcomeId>DgFc7wkzfUU-3</gtr:outcomeId><gtr:partnerContribution>Developing an understanding of immunogenetics and nutritional aspects of IRIS in TB/HIV co-infected patients.See above.See above.</gtr:partnerContribution><gtr:piContribution>One of 3 sites contributing clinical and laboratory data. All sites participated in analysis of results and dissemination of findings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Durban IRIS Collaborative research group</gtr:description><gtr:id>FFBC99E9-9C87-48F9-9D04-829ACF88A3D0</gtr:id><gtr:impact>All publications to date are a product of combined work with the dept of ID in UKZN and some or all of the other collaborators</gtr:impact><gtr:outcomeId>703A767455B-4</gtr:outcomeId><gtr:partnerContribution>This is the lead department for this research groupProvided laboratory support for the HIV cohort studyProvided clinical sites for conducting cohort studiesCollaborated on a substudy of cytokine responses in cases and controls within the clinical cohortThe Network is itself a collaborative group, of which we are a part. The Network aims to foster collaboration in clinical and laboratory research on all aspects of IRIS. We have had a specific collaboration in the development of case definitions of the syndrome</gtr:partnerContribution><gtr:piContribution>Working in partnership with Professor Yunus Moosa, head of department of Infectious Diseases in University of KwaZulu-Natal. Dr Haddow (the primary grant holder) was based in Durban at UKZN for 2 years, with Prof Moosa as supervisor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of South Africa</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Department of Health</gtr:department><gtr:description>Durban IRIS Collaborative research group</gtr:description><gtr:id>AC824F46-34E6-4639-8C13-724D82B78395</gtr:id><gtr:impact>All publications to date are a product of combined work with the dept of ID in UKZN and some or all of the other collaborators</gtr:impact><gtr:outcomeId>703A767455B-3</gtr:outcomeId><gtr:partnerContribution>This is the lead department for this research groupProvided laboratory support for the HIV cohort studyProvided clinical sites for conducting cohort studiesCollaborated on a substudy of cytokine responses in cases and controls within the clinical cohortThe Network is itself a collaborative group, of which we are a part. The Network aims to foster collaboration in clinical and laboratory research on all aspects of IRIS. We have had a specific collaboration in the development of case definitions of the syndrome</gtr:partnerContribution><gtr:piContribution>Working in partnership with Professor Yunus Moosa, head of department of Infectious Diseases in University of KwaZulu-Natal. Dr Haddow (the primary grant holder) was based in Durban at UKZN for 2 years, with Prof Moosa as supervisor</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Minnesota</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Network for the Study of HIV-Associated IRIS (INSHI)</gtr:department><gtr:description>Durban IRIS Collaborative research group</gtr:description><gtr:id>1D5C6A18-0D42-42D3-9374-823C3289D067</gtr:id><gtr:impact>All publications to date are a product of combined work with the dept of ID in UKZN and some or all of the other collaborators</gtr:impact><gtr:outcomeId>703A767455B-5</gtr:outcomeId><gtr:partnerContribution>This is the lead department for this research groupProvided laboratory support for the HIV cohort studyProvided clinical sites for conducting cohort studiesCollaborated on a substudy of cytokine responses in cases and controls within the clinical cohortThe Network is itself a collaborative group, of which we are a part. The Network aims to foster collaboration in clinical and laboratory research on all aspects of IRIS. We have had a specific collaboration in the development of case definitions of the syndrome</gtr:partnerContribution><gtr:piContribution>Working in partnership with Professor Yunus Moosa, head of department of Infectious Diseases in University of KwaZulu-Natal. Dr Haddow (the primary grant holder) was based in Durban at UKZN for 2 years, with Prof Moosa as supervisor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>School of Pathology and Laboratory Medicine</gtr:department><gtr:description>Vitamin D and TB-associated IRIS</gtr:description><gtr:id>88A17939-1722-45B4-8F36-B7E410B40B7D</gtr:id><gtr:impact>The collaboration involves immunology, genetics and epidemiology expertise.
Abstract presented at Australasian HIV/AIDS Conference 2011. (Paper submitted for publication.)</gtr:impact><gtr:outcomeId>DgFc7wkzfUU-1</gtr:outcomeId><gtr:partnerContribution>Developing an understanding of immunogenetics and nutritional aspects of IRIS in TB/HIV co-infected patients.See above.See above.</gtr:partnerContribution><gtr:piContribution>One of 3 sites contributing clinical and laboratory data. All sites participated in analysis of results and dissemination of findings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of KwaZulu-Natal</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Department of Virology</gtr:department><gtr:description>Durban IRIS Collaborative research group</gtr:description><gtr:id>E7FF3E33-6844-4484-9F80-BA31E56F6FD5</gtr:id><gtr:impact>All publications to date are a product of combined work with the dept of ID in UKZN and some or all of the other collaborators</gtr:impact><gtr:outcomeId>703A767455B-2</gtr:outcomeId><gtr:partnerContribution>This is the lead department for this research groupProvided laboratory support for the HIV cohort studyProvided clinical sites for conducting cohort studiesCollaborated on a substudy of cytokine responses in cases and controls within the clinical cohortThe Network is itself a collaborative group, of which we are a part. The Network aims to foster collaboration in clinical and laboratory research on all aspects of IRIS. We have had a specific collaboration in the development of case definitions of the syndrome</gtr:partnerContribution><gtr:piContribution>Working in partnership with Professor Yunus Moosa, head of department of Infectious Diseases in University of KwaZulu-Natal. Dr Haddow (the primary grant holder) was based in Durban at UKZN for 2 years, with Prof Moosa as supervisor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of KwaZulu-Natal</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Department of Infectious Diseases</gtr:department><gtr:description>Durban IRIS Collaborative research group</gtr:description><gtr:id>82EB5C6F-50BF-405B-A3E2-1132EFF97939</gtr:id><gtr:impact>All publications to date are a product of combined work with the dept of ID in UKZN and some or all of the other collaborators</gtr:impact><gtr:outcomeId>703A767455B-1</gtr:outcomeId><gtr:partnerContribution>This is the lead department for this research groupProvided laboratory support for the HIV cohort studyProvided clinical sites for conducting cohort studiesCollaborated on a substudy of cytokine responses in cases and controls within the clinical cohortThe Network is itself a collaborative group, of which we are a part. The Network aims to foster collaboration in clinical and laboratory research on all aspects of IRIS. We have had a specific collaboration in the development of case definitions of the syndrome</gtr:partnerContribution><gtr:piContribution>Working in partnership with Professor Yunus Moosa, head of department of Infectious Diseases in University of KwaZulu-Natal. Dr Haddow (the primary grant holder) was based in Durban at UKZN for 2 years, with Prof Moosa as supervisor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Society for Antimicrobial Chemotherapy Research Grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>British Society for Antimicrobial Chemotherapy</gtr:fundingOrg><gtr:id>4241B13B-51F7-43AF-965B-FCC8DDAEB24A</gtr:id><gtr:outcomeId>B9BDF7CFBB20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Two proposed case definitions for use in future epidemiological and immunopathological studies of IRIS, and in clinical trials</gtr:description><gtr:id>5017752A-4D95-49FC-9FE8-CB838DBD8715</gtr:id><gtr:impact>Publication in Clinical Infectious Diseases</gtr:impact><gtr:outcomeId>FC82720E5E3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Generic case definition of Immune Reconstitution Disease</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The collaboration and set-up of the current cohort study have led to further immunopathological studies between Durban and Australia</gtr:description><gtr:id>6D88F69E-22D5-47CE-84D8-F3DDBDACF33F</gtr:id><gtr:impact>As above</gtr:impact><gtr:outcomeId>1929001B55C</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Durban Collaborative IRIS Research Group</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>55BE0FA1-6842-43EE-909E-E606C2063645</gtr:id><gtr:title>Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>hFH9VfNvwBL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD53A8F3-0F77-41F5-80F2-4BE0FB0D7ED0</gtr:id><gtr:title>Histopathology of Strongyloides stercoralis hyperinfection during immune reconstitution in an HIV-infected patient.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>7AF07A59347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB75BA6-C8F0-4E1A-8BF5-9E0746C9E381</gtr:id><gtr:title>Cryptococcal breast abscess in an HIV-positive patient: arguments for reviewing the definition of immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>60899D7ADA5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDD71BB1-8D6D-428F-9E4D-DD6ECA07C4AB</gtr:id><gtr:title>Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>1C25324BF8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1FF54B9-3D5E-4C84-9C9C-8B921285DF98</gtr:id><gtr:title>Sweet syndrome: adverse drug reaction or novel manifestation of HIV-associated immune reconstitution inflammatory syndrome?</gtr:title><gtr:parentPublicationTitle>Journal of the American Academy of Dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0190-9622</gtr:issn><gtr:outcomeId>UcTxoxEzhfX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C5851AE-DE27-47E5-A2C1-4A51493F3AD9</gtr:id><gtr:title>Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>55F982ED475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19E0CB14-27B5-4224-A453-EFBD975F307F</gtr:id><gtr:title>Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>sz71GBE8Jvd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C0345F4-2EA1-45D4-BA5B-356CE0117BBC</gtr:id><gtr:title>Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900775a7ed52efc0681414b81b943247"><gtr:id>900775a7ed52efc0681414b81b943247</gtr:id><gtr:otherNames>Price P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>pm_12962_22_22280097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCC3DFEA-AC85-4F5B-A249-4983B15D6F52</gtr:id><gtr:title>Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.</gtr:title><gtr:parentPublicationTitle>International journal of STD &amp; AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0956-4624</gtr:issn><gtr:outcomeId>pm_540e153e153b0d4d7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>044A0363-F873-4D26-A826-7B7961E977E2</gtr:id><gtr:title>Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e345a59be0d9dbf7c4f00fdd87a8717e"><gtr:id>e345a59be0d9dbf7c4f00fdd87a8717e</gtr:id><gtr:otherNames>Oliver BG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>pm_12962_22_23666138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3D071E3-0778-4440-9005-987BFEA30DAD</gtr:id><gtr:title>Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67bf0438df67a346b08f5f6dcc5e0e0b"><gtr:id>67bf0438df67a346b08f5f6dcc5e0e0b</gtr:id><gtr:otherNames>Haddow LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12962_22_23152745</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700530</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>